Atractylenolide III Attenuates Angiogenesis in Gastric Precancerous Lesions Through the Downregulation of Delta-Like Ligand 4

• Main Authors: Ying Gao (Author), Jundong Wang (Author), Maoyuan Zhao (Author), Ting Xia (Author), Qingsong Liu (Author), Nianzhi Chen (Author), Wenhao Liao (Author), Zhongzhen Zeng (Author), Fengming You (Author), Jinhao Zeng (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Blocking and even reversing gastric precancerous lesions (GPL) is a key measure to lower the incidence of gastric cancer. Atractylenolide III (AT-III) is a mainly active component of the Atractylodes rhizome and has been widely used in tumor treatment. However, the effects of AT-III on G...